Nano-X Imaging (NNOX) said Thursday that the US Food and Drug Administration has approved its Nanox.ARC X imaging system.
The company said Nanox.ARC X features its digital Nanox.SOURCE and advanced tomosynthesis technology.
The approval covers the system's production of tomographic images for general use, the company added.
Nano-X Imaging said it is set to start offering Nanox.ARC X later this year.
Price: 4.95, Change: +0.45, Percent Change: +10.00
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。